| PESAB02 | In-hospital mortality among persons with HIV (PWH) in the US and Canada, 2005-2018 | Poster exhibition | Morbidity, mortality and life expectancy in clinical research |
| PESAB03 | High accuracy of an enzyme-linked immunoasssay for detection of tenofovir alafenamide: implications for point-of-care antiretroviral adherence monitoring | Poster exhibition | Adherence testing |
| PESAB04 | Comparison of Advanced HIV Disease identification using CD4 results from a semi-quantitative CD4 point of care test and CD4 flow cytometry in Nigeria | Poster exhibition | Viral load and CD4 monitoring |
| PESAB05 | Circulating mir21 and mir125b in women living with human immunodeficiency virus: utility of biomarkers for monitoring cervical carcinogenesis | Poster exhibition | Diagnostics of co-infections and co-morbidities |
| PESAB06 | Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with HIV-associated cryptococcosis | Poster exhibition | Diagnostics of co-infections and co-morbidities |
| PESAB07 | Antenatal systemic inflammation and mortality of children born to mothers with HIV in rural Zimbabwe | Poster exhibition | Biomarkers for the prediction of morbidity and mortality |
| PESAB08 | Viral suppression among adults with HIV receiving dolutegravir-based antiretroviral therapy and 3HP in Kampala, Uganda | Poster exhibition | Tuberculosis: Prevention, diagnosis, treatment |
| PESAB09 | Pharmacokinetic and 48 week efficacy of once-daily vs twice-daily dolutegravir among patients with human immunodeficiency virus/tuberculosis coinfection receiving rifampicin based tuberculosis therapy: a randomized control trial | Poster exhibition | Tuberculosis: Prevention, diagnosis, treatment |
| PESAB10 | Sitafloxacin therapy for mycoplasma genitalium in men who have sex with men | Poster exhibition | STIs (including HPV) |
| PESAB11 | The acceptability of the AMBITION treatment regimen for HIV-associated cryptococcal meningitis: findings from a qualitative study of patients and providers in Botswana and Uganda | Poster exhibition | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |